Future Developments in Neoadjuvant Therapy for Triple-Negative Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Surgery
Reference49 articles.
1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017
2. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study;Carey;JAMA,2006
3. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin Cancer Res,2007
4. Molecular classification of triple-negative breast cancer;Ahn;J Breast Cancer,2016
5. Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group;Kinne;Arch Surg,1987
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Subpopulation treatment effect pattern plot analysis: a prognostic model for distant recurrence-free survival to estimate delayed adjuvant chemotherapy initiation effect in triple-negative breast cancer;Frontiers in Oncology;2023-11-06
2. Ultrasound-enhanced theranostics of orthotopic breast cancer through a multifunctional core–shell tecto dendrimer-based nanomedicine platform;Biomaterials Science;2023
3. Research Prospects for Neoadjuvant Treatment for Breast Cancer;Advances in Clinical Medicine;2023
4. Fabatin-loaded silica nanoparticle-induced apoptosis via mitochondrial dysfunction: targeting the PI3K/AKT molecular pathway as a therapeutic implication against triple negative breast cancer;New Journal of Chemistry;2021
5. Chemopreventive and Chemosensitizing Effects of Green Tea: An Evidence-based Review;Pakistan Journal of Zoology;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3